Cherilyn Rohr
Sr. Director, Clinical Operations at Atara Biotherapeutics | Camarillo, California, United States
Cherilyn Rohr’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Sr. Director, Clinical Operations at Atara Biotherapeutics in March 2024 - Present
Director, Clinical Operations at Atara Biotherapeutics in August 2021 - February 2024
Associate Director, Clinical Operations at Atara Biotherapeutics in May 2020 - August 2021
Walden University, Masters, Business Administration, January 2006 to January 2008
University of Maryland Baltimore County, Bachelor's of Science, January 2001 to January 2005
Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.
Discover more about Atara BiotherapeuticsSenior Director Of Quality | External Quality Leader @ Atara Biotherapeutics
Senior Director Of Quality at Atara Biotherapeutics
(May 2019 – Present)
VP Clinical Operations at Atara Biotherapeutics
Associate Director, Medical Research, Medical Affairs at Amgen
(August 2026 – August 2026)
Sr. Manager, Medical Writing at Moderna
Sr. Manager, Medical Writing at Moderna
(May 2024 – Present)
Company-builder, founder, and strategic operator with a strong passion for developing early-stage technologies in biopharma from vision to execution.
Director & Co-founder at Oxeia Biopharmaceuticals Inc
(January 2014 – Present)
finance at verily life sciences
Finance Lead at Verily
(March 2024 – Present)
CMC Strategy | Cell & Gene Therapy | Regulatory Submissions | Process Development & CDMO Management | Viral Vectors | Cell Line Engineering | Drug Discovery
Post Doctoral Fellow at University of California, Los Angeles
(June 2014 – August 2026)
What is Cherilyn Rohr email address?
Email Cherilyn Rohr at [email protected], [email protected] and [email protected]. This email is the most updated Cherilyn Rohr's email found in 2026.
How to contact Cherilyn Rohr?
To contact Cherilyn Rohr send an email to [email protected], [email protected] or [email protected].
What company does Cherilyn Rohr work for?
Cherilyn Rohr works for Atara Biotherapeutics.
What is Cherilyn Rohr's role at Atara Biotherapeutics?
Cherilyn Rohr is Sr. Director, Clinical Operations
What industry does Cherilyn Rohr work in?
Cherilyn Rohr works in the Biotechnology industry.